Solara Active Pharma Sciences Limited — Important, 07-02-2025: General Updates

The Board Committee of Solara Active Pharma Sciences Limited has approved the incorporation of a wholly-owned subsidiary to facilitate the proposed demerger of its CRAMS and Polymers Business into an independent listed entity. The targeted subsidiary's name will be determined by the Ministry of Corporate Affairs upon incorporation. As the subsidiary is not yet established, financial figures and operational metrics are currently unavailable. This strategic move aims to streamline business operations and enhance focus, potentially leading to improved performance in relevant sectors. Investors should watch closely as the demerger progresses, as it could unlock significant value, positioning Solara for future growth opportunities.